drugset / Trial / NCT04445337
Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients
RandomizedParallel-groupOpen-labelPrevention
Summary
This study will establish the safety and efficacy of using stellate ganglion blocks in patients with acute respiratory distress syndrome (ARDS) due to COVID-19 disease.
Timeline
- Start
- 2020-11-15
- Primary completion
- 2021-10-01
- Completion
- 2021-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Bupivacaine | Other / unclassified | 2 ml | Other |
| Background | Clonidine | Other / unclassified | 100 ug | Other |
| Background | Dexamethasone | Small molecule | 5 mg | Other |